SEC SUSPECTS INSIDER TRADING IN GLAXO-CNS DEAL

The U.S. Securities and Exchange Commission is hunting for investors suspected of profiting from advanced knowledge of GlaxoSmithKline PLC's takeover bid for CNS Inc.

Toronto Star (http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Article_Type1&col=969048863851&c=Article&cid=1160689837705&call_pageid=968350072197)